Keyphrases
Acute Kidney Injury
80%
Continuous Renal Replacement Therapy
58%
Renal Replacement
58%
Kidney Disease
58%
Chronic Kidney Disease
39%
Pediatric Acute Kidney Injury
39%
Rabbit Erythrocytes
39%
Older Adults
39%
Human Erythrocytes
35%
Iloprost
26%
Receptor-mediated
22%
Erythrocytes
21%
Injury Management
19%
Clinical Data
19%
Injury Outcomes
19%
Adenosine Triphosphate Production
19%
Administrative Data
19%
Isoproterenol
19%
Prostaglandin Analogs
19%
Phosphodiesterase
19%
Late Development
19%
Injury Rate
19%
Cyclic Adenosine Monophosphate (cAMP)
19%
Management Challenges
19%
Acute Kidney Injury Biomarkers
19%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
19%
Cystatin C (Cys C)
19%
Disease Registry
19%
Biomedical Informatics
19%
IP Receptor
14%
Serum Creatinine
14%
Serum Cystatin C
14%
Patient Care
14%
Epidemiology
14%
Relational Database
13%
PGI2
13%
Urine Output
11%
Severity Stratification
9%
Pediatric Population
9%
Early Detection
9%
ATP Release
9%
Low Risk
9%
Tissue Injury
9%
Injury Risk
9%
Response-to-intervention
9%
Dose Effect
9%
Clinical Setting
9%
Risk Severity
9%
Therapy Initiation
9%
Intensive Care Unit Discharge
8%
Medicine and Dentistry
Acute Kidney Injury
100%
Renal Replacement
97%
Nephropathy
78%
Continuous Renal Replacement Therapy
64%
Pediatrics
55%
Continuous Kidney Replacement Therapy
39%
Intensive Care Unit
35%
Biological Marker
24%
Sepsis
21%
Chronic Kidney Disease
19%
Prevalence
19%
Kidney Disorder
19%
Hypervolemia
15%
Cohort Effect
11%
Neonatal Intensive Care Unit
11%
Fluid Balance
10%
Neutrophil Gelatinase Associated Lipocalin
7%
Anticoagulation
7%
Retrospective Study
6%
Diagnosis
6%
Renal Replacement Therapy
6%
Odds Ratio
6%
Electronic Health Record
5%